These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34334787)

  • 1. Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease.
    Courbon G; Francis C; Gerber C; Neuburg S; Wang X; Lynch E; Isakova T; Babitt JL; Wolf M; Martin A; David V
    Bone Res; 2021 Aug; 9(1):35. PubMed ID: 34334787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipocalin-2: a novel link between the injured kidney and the bone.
    Courbon G; David V
    Curr Opin Nephrol Hypertens; 2022 Jul; 31(4):312-319. PubMed ID: 35727169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease.
    Dussold C; Gerber C; White S; Wang X; Qi L; Francis C; Capella M; Courbon G; Wang J; Li C; Feng JQ; Isakova T; Wolf M; David V; Martin A
    Bone Res; 2019; 7():12. PubMed ID: 31044094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
    Francis C; Courbon G; Gerber C; Neuburg S; Wang X; Dussold C; Capella M; Qi L; Isakova T; Mehta R; Martin A; Wolf M; David V
    Kidney Int; 2019 Dec; 96(6):1346-1358. PubMed ID: 31668632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
    David V; Martin A; Isakova T; Spaulding C; Qi L; Ramirez V; Zumbrennen-Bullough KB; Sun CC; Lin HY; Babitt JL; Wolf M
    Kidney Int; 2016 Jan; 89(1):135-46. PubMed ID: 26535997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.
    Stubbs JR; He N; Idiculla A; Gillihan R; Liu S; David V; Hong Y; Quarles LD
    J Bone Miner Res; 2012 Jan; 27(1):38-46. PubMed ID: 22031097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model.
    Dai B; David V; Martin A; Huang J; Li H; Jiao Y; Gu W; Quarles LD
    PLoS One; 2012; 7(9):e44161. PubMed ID: 22970174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100/RAGE and FGF23.
    Yan L; Bowman MA
    Inflamm Cell Signal; 2014; 1(5):. PubMed ID: 26082935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.
    Hanudel MR; Chua K; Rappaport M; Gabayan V; Valore E; Goltzman D; Ganz T; Nemeth E; Salusky IB
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1369-F1377. PubMed ID: 27733366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Fibroblast Growth Factor 23 Excess Does Not Induce Left Ventricular Hypertrophy in Healthy Mice.
    Leifheit-Nestler M; Wagner MA; Richter B; Piepert C; Eitner F; Böckmann I; Vogt I; Grund A; Hille SS; Foinquinos A; Zimmer K; Thum T; Müller OJ; Haffner D
    Front Cell Dev Biol; 2021; 9():745892. PubMed ID: 34778257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation.
    Bansal S; Friedrichs WE; Velagapudi C; Feliers D; Khazim K; Horn D; Cornell JE; Werner SL; Fanti P
    Nephrol Dial Transplant; 2017 Jun; 32(6):960-968. PubMed ID: 27836924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
    Durlacher-Betzer K; Hassan A; Levi R; Axelrod J; Silver J; Naveh-Many T
    Kidney Int; 2018 Aug; 94(2):315-325. PubMed ID: 29861060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD).
    Noonan ML; Clinkenbeard EL; Ni P; Swallow EA; Tippen SP; Agoro R; Allen MR; White KE
    Physiol Rep; 2020 Jun; 8(11):e14434. PubMed ID: 32476270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.
    Viau A; El Karoui K; Laouari D; Burtin M; Nguyen C; Mori K; Pillebout E; Berger T; Mak TW; Knebelmann B; Friedlander G; Barasch J; Terzi F
    J Clin Invest; 2010 Nov; 120(11):4065-76. PubMed ID: 20921623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.
    Czaya B; Faul C
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF23 induces left ventricular hypertrophy.
    Faul C; Amaral AP; Oskouei B; Hu MC; Sloan A; Isakova T; Gutiérrez OM; Aguillon-Prada R; Lincoln J; Hare JM; Mundel P; Morales A; Scialla J; Fischer M; Soliman EZ; Chen J; Go AS; Rosas SE; Nessel L; Townsend RR; Feldman HI; St John Sutton M; Ojo A; Gadegbeku C; Di Marco GS; Reuter S; Kentrup D; Tiemann K; Brand M; Hill JA; Moe OW; Kuro-O M; Kusek JW; Keane MG; Wolf M
    J Clin Invest; 2011 Nov; 121(11):4393-408. PubMed ID: 21985788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation regulates fibroblast growth factor 23 production.
    Francis C; David V
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):325-32. PubMed ID: 27191351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia.
    Figurek A; Rroji M; Spasovski G
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.